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ORIGINAL ARTICLE
Gemella bacteraemia characterised by 16S ribosomal
RNA gene sequencing
P C Y Woo, S K P Lau, A M Y Fung, S K Chiu, R W H Yung, K Y Yuen
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J Clin Pathol 2003;56:690–693
Aims: To define epidemiology, clinical disease, and outcome of gemella bacteraemia by 16S rRNA
gene sequencing. To examine the usefulness of the Vitek, API, and ATB systems in identifying two
gemella species.
Methods: All α haemolytic streptococci other than Streptococcus pneumoniae isolated from blood cul-
tures during a six year period were identified by conventional biochemical methods, the Vitek system,
and the API system. 16S rRNA gene sequencing was performed on all isolates identified by both kits
as gemella with > 95% confidence or by either kit as any bacterial species with < 95% confidence.
The ATB expression system was used to identify the two isolates that were defined as gemella species
by 16S rRNA gene sequencing.
Results: Of the 302 α haemolytic streptococci other than S pneumoniae isolated, one was identified
as Gemella morbillorum, and another as Gemella haemolysans by 16S rRNA gene sequencing. The
patient with monomicrobial G morbillorum bacteraemia was a 66 year old man with community
acquired infective endocarditis with septic thromboemboli. The patient with G haemolysans bacterae-
mia was a 41 year old woman with hospital acquired polymicrobial bacteraemia during the
neutropenic period of an autologous bone marrow transplant for non-Hodgkin’s lymphoma, the first
case of its kind in the English literature. The API and ATB expression systems only identified the second
strain as G haemolysans at 94% and 99% confidence, respectively, whereas the Vitek system identi-
fied none of the two strains correctly at > 70% confidence.
Conclusions: Gemella bacteraemia is uncommon. 16S rRNA gene sequencing is the method of
choice for identification of gemella and gemella-like isolates.
Since the discovery of the polymerase chain reaction(PCR) and DNA sequencing, comparisons of the genesequences of bacterial species have shown that the 16S
rRNA gene is highly conserved within a species and among
species of the same genus, and hence can be used as the new
standard for speciation of bacteria.1 Using this new standard,
phylogenetic trees, based on base differences between species,
are constructed, and bacteria are classified and reclassified
into new genera. Recently, we have reported the use of this
technique for the identification of bacterial strains with
ambiguous biochemical profiles,2–10 species that are rarely
encountered clinically,11–15 and a bacterium that is non-
cultivable.16 In addition, we have also reported the discovery of
a novel clinical syndrome17 18 and three novel species,19–21 and
the characterisation of β haemolytic Lancefield group G strep-
tococcal bacteraemia and Granulicatella adiacens and Abiotrophia
defectiva bacteraemia.22 23
“We have recently shown that a large number of bacte-
rial strains identified as gemella species by commercially
available phenotypic systems are actually Granulicatella
adiacens”
Members of the genus gemella consist of catalase negative,
facultative anaerobic, Gram positive cocci that phenotypically
resemble viridans streptococci. Traditionally, the identification
of, and hence the study in the epidemiology of and spectrum
of clinical diseases caused by gemella species depend on the
phenotypic characterisation of suspected isolates.However,we
have recently shown that a large number of bacterial strains
identified as gemella species by commercially available
phenotypic systems are actually Granulicatella adiacens.23 No
data are currently available that have used 16S rRNA gene
sequencing as the gold standard. Therefore, in our study, we
used 16S rRNA gene sequencing, assisted by traditional phe-
notypic tests, to describe the epidemiology, clinical diseases,
and outcome of gemella bacteraemia. We also examined the
usefulness of the Vitek system (bioMerieux Vitek, Hazelwood,
Missouri, USA), the API system (bioMerieux Vitek), and the
ATB expression system (bioMerieux Vitek), which are
commonly used for microbial identification of α haemolytic
streptococci in clinical microbiology laboratories, for the iden-
tification of the two gemella isolates.
METHODS AND MATERIALS
Patients and microbiological methods
The patients with gemella bacteraemia in our study were hos-
pitalised at the Queen Mary Hospital in Hong Kong during a
six year period (July 1995 to June 2001). All clinical data were
collected as described in our previous publication.24 The
BACTEC 9240 blood culture system (Becton Dickinson,
Sparks, Maryland, USA) was used. To identify potential cases
of gemella bacteraemia, in addition to identifying all blood
culture isolates by standard conventional biochemical
methods,25 the Vitek system (GPI; bioMerieux Vitek) and the
API system (20 STREP; bioMerieux Vitek) were used for spe-
cies identification of all α haemolytic streptococci other than
Streptococcus pneumoniae isolated from blood cultures during
the six year period. 16S rRNA gene sequencing was performed
on all isolates that were identified by both kits as gemella with
> 95% confidence, or by either kit as any bacterial species with
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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< 95% confidence. To examine the usefulness of the ATB
expression system (ID32 STREP; bioMerieux Vitek) for the
identification of gemella species, this system was also used for
identification of the two isolates that were finally defined as
gemella species by 16S rRNA gene sequencing. Antimicrobial
susceptibility was undertaken by the E test for penicillin and
the Kirby Bauer disk diffusion method for the other antibiot-
ics using Muller Hinton agar supplemented with 5% horse
blood, and the results were interpreted according to the
NCCLS criteria for α haemolytic streptococci.Multiple positive
blood cultures with the same isolate obtained from the same
patient were counted only once.
Extraction of bacterial DNA for 16S rRNA gene
sequencing
Bacterial DNA extraction was modified from our previously
published protocol.26 Briefly, 80 µl of NaOH (0.05M) was
added to 20 µl of bacterial cells suspended in distilled water
and the mixture was incubated at 60°C for 45 minutes,
followed by the addition of 6 µl of Tris/HCl (pH 7.0), to achieve
a final pH of 8.0. The resultant mixture was diluted ×100 and
5 µl of the diluted extract was used for PCR.
PCR, gel electrophoresis, and 16S rRNA gene
sequencing
PCR amplification and DNA sequencing of the 16S rRNA
genes were performed according to our previous
publications.9 20 22 23 Briefly, DNase I treated distilled water and
the PCR master mix (which contains dNTPs, PCR buffer, and
Taq polymerase) were used in all PCR reactions by adding 1 U
of DNase I (Pharmacia, Uppsala, Sweden) to 40 µl of distilled
water or PCR master mix, incubating the mixture at 25°C for
15 minutes, and subsequently at 95°C for 10 minutes to inac-
tivate the DNase I. The bacterial DNA extracts and control
were amplified with 0.5µM primers (LPW200, 5′-
GAGTTGCGAACGGGTGAG-3′; and LPW205, 5′-
CTTGTTACGACTTCACCC-3′; Gibco BRL, Rockville, Maryland,
USA). The PCR mixture (50 µl) contained bacterial DNA, PCR
buffer (10mM Tris/HCl, pH 8.3, 50mM KCl, 2mM MgCl2, and
0.01% gelatin), 200 µM of each dNTP and 1.0 U Taq polymer-
ase (Boehringer Mannheim, Mannheim, Germany). The mix-
tures were amplified by 40 cycles of 94°C for one minute, 55°C
for one minute, and 72°C for two minutes, with a final exten-
sion at 72°C for 10 minutes in an automated thermal cycler
(Perkin-Elmer Cetus, Gouda, The Netherlands). DNase I
treated distilled water was used as the negative control. A
10 µl sample of each amplified product was electrophoresed in
a 1.0% (wt/vol) agarose gel, with a molecular size marker
(Lambda DNA AvaII digest; Boehringer Mannheim) in paral-
lel. Electrophoresis in Tris/borate/EDTA buffer was performed
at 100 V for 1.5 hours. The gel was stained with ethidium bro-
mide (0.5 µg/ml) for 15 minutes, rinsed, and photographed
under ultraviolet light illumination.
The PCR products were gel purified using the QIAquick PCR
purification kit (QIAgen, Hilden, Germany). Both strands of
the PCR products were sequenced twice with an ABI 377
automated sequencer according to manufacturer’s instruc-
tions (Perkin-Elmer, Foster City, California, USA), using the
primers LPW200, LPW205, LPW99 (5′-
TTATTGGGCGTAAAGCGA-3′), and LPW273 (5′-
TTGCGGGACTTAACCCAAC-3′). The sequences of the PCR
products were compared with known 16S rRNA gene
sequences in the GenBank by multiple sequence alignment
using the CLUSTAL W program,27 and phylogenetic tree
construction was performed using the PileUp method with
GrowTree (Genetics Computer Group Inc, San Diego, USA).
RESULTS
16S rRNA gene sequencing
Among a total of 302 α haemolytic streptococci other than
S pneumoniae isolated from blood cultures of patients admitted
to Queen Mary Hospital during the six year period (July 1995
to June 2001), none was identified by both the Vitek system
(GPI) and the API system (20 STREP) as any gemella species
with > 95% confidence. A total of 74 were identified by either
kit as any species with < 95% confidence. PCR of the 16S
rRNA genes of these isolates showed bands at approximately
1410 bp. Sequencing of the 16S rRNA genes revealed that one
isolate (table 1; patient 1) had > 99% nucleotide identity with
the 16S rRNA genes of G morbillorum (GenBank accession
number L14327), and another (table 1; patient 2) had > 99%
nucleotide identity with the 16S rRNA genes of G haemolysans
(GenBank accession number L14326) (fig 1). Therefore,
gemella accounted for 0.7% of bacteraemia caused by
α haemolytic streptococci other than S pneumoniae.




Year of isolation 1997 2000
Age/sex 66/M 41/F
Underlying disease Abdominal aortic aneurysm Non-Hodgkin lymphoma,
autologous bone marrow
transplant




Community/hospital acquired Community Hospital
Number of positive blood cultures 3 1
Monomicrobial/polymicrobial bacteraemia Monomicrobial Polymicrobial (with
Streptococcus mitis and
Escherichia coli)
Positive cultures from other specimens None None







Treatment Penicillin G+netilmicin Imipenem
Outcome Remission Remission
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Phenotypic characterisation and identification of
gemella by commercial systems
Gram smears of the two isolates showed Gram positive cocci in
pairs. The Vitek System (GPI) identified the G morbillorum and
G haemolysans strains as 63% G morbillorum/S agalactiae/
S acidominimus, 22% S pneumoniae, and 68% G morbillorum/
S agalactiae/S acidominimus, 24% S pneumoniae, respectively. The
API system (20 STREP) identified the G morbillorum and
G haemolysans strains as 60% Leuconostoc sp., 28% Streptococcus
mitis, and 94% G haemolysans, 6% G morbillorum, respectively.
The ATB expression system (ID32 STREP) identified the
G morbillorum and G haemolysans strains as “unidentified” and
99% G haemolysans, respectively.
Patient characteristics
Table 1 summarises the characteristics of the two patients with
gemella bacteraemia. Briefly, the first patient, a 66 year oldman,
was admitted because of occasional abdominal and low back
pain for one month. He was afebrile. Examination revealed a
collapsing pulse, an early diastolic murmur of grade 3/6 at the
left lower sternal border, and a pulsatile mass in the abdomen.
Computer tomography of the abdomen confirmed an infrarenal
abdominal aortic aneurysm of 7.5 cm in diameter,without signs
of rupture. Transthoracic echocardiogram showed severe aortic
regurgitation and vegetations on both the aortic and mitral
valves. Three sets of blood cultures all recovered the same strain
of G morbillorum. He was treated for community acquired infec-
tive endocarditis with intravenous penicillin G and netilmicin.
He developed sudden retrograde amnesia 17 days after
admission. Magnetic resonance imaging of the brain showed
multiple subacute infarcts at both occipito–temporal regions,
compatible with septic thromboembolism. Intravenous antibi-
otics were continued for a total of six weeks with residual
memory loss. He subsequently underwent an elective endoan-
eurysmectomy with insertion of an aortic graft and was
discharged two months from admission.
The second patient, a 41 year old woman with non-
Hodgkin’s lymphoma, was admitted because of autologous
bone marrow transplantation. On day two postmarrow
infusion, she developed neutropenic fever. Examination did
not reveal a heart murmur or other focus of infection. Blood
cultures were performed and recovered G haemolysans, S mitis,
and Escherichia coli. She responded to empirical intravenous
imipenem and subsequent blood cultures were negative. Her
bone marrow engrafted on day 15.
DISCUSSION
The identification of infrequently encountered bacterial species
in clinical microbiology laboratories has always been a problem.
Because the number of reference strains used for building up
databases in commercial kits is usually small for rare bacteria, it
is not uncommon to encounter clinical isolates of these rare
bacterial species with ambiguous biochemical profiles. Further-
more, even if they are “successfully” identified by the commer-
cial kits, the low prevalence rate would imply a low positive pre-
dictive value. In our study,we described our experience in using
16S rRNA gene sequencing to characterise two strains of a
rarely encountered bacterial genus, gemella, recovered from
blood cultures of our patients in the past six years.
The genus gemella consists of six species. Before 1998, there
were only two known gemella species,G haemolysans and G mor-
billorum.Gemella haemolysanswas originally classified asNeisseria
haemolysans,28 and was subsequently reclassified as G haemoly-
sans in 1960; whereas G morbillorum was originally classified as
Diplococcus morbillorum,29 subsequently as Peptostreptococcus mor-
billorum and Streptococcus morbillorum, and was finally reclassi-
fied as G morbillorum in 1988.30 In the past five years, four addi-
tionalGemella species have been discovered.Gemella bergeriae and
G sanguinis were recovered from human clinical specimens,31 32
whereas G palaticanis was recovered from the oral cavity of a
dog,33 and G cunicula from an abscess of a rabbit.34
The identification of “gemella-like” species by the commer-
cial kits was unsatisfactory, especially when the Vitek system
(GPI) was used. In the present series, the Vitek system (GPI)
was not able to identify a single isolate successfully,whereas the
API system (20 STREP) and the ATB expression system (ID32
STREP)were only able to identify one of the two gemella species
correctly. This poor accuracy in identifying gemella species by
commercial kits was also demonstrated in a recent study, in
which none of the three gemella species was successfully iden-
tified by the rapid phenotypic identification systems.35 Interest-
ingly, among the nine isolates of Granulicatella adiacens and A de-
fectiva that we reported recently, the Vitek system (GPI)
incorrectly identified seven of them as gemella, and the API
system (20 STREP) and the ATB expression system (ID32
STREP) incorrectly identified one of them as gemella.23
Therefore, we think that 16S rRNA gene sequencing should be
used as the method of choice for identifying gemella and
“gemella-like” species.
Species of gemella are important causes of infective
endocarditis. Among the reported cases of gemella infections,
infective endocarditis is the most common diagnosis. Over 25
cases of gemella endocarditis have been reported in the litera-
ture, with the incidence of G morbillorum and G haemolysans
endocarditis being approximately the same.36 In our present
report, one of the two patients had gemella endocarditis.
However, further studies using 16S rRNA gene sequencing
need to be carried out to ascertain the true incidence of
gemella endocarditis, because gemella species are frequently
misidentified as species of streptococcus, leuconostoc, and
abiotrophia, and granunicatella and abiotrophia species are
frequently misidentified as species of gemella.
“We think that 16S rRNA gene sequencing should be
used as the method of choice for identifying gemella and
gemella-like species”
We report the first case of gemella bacteraemia during the
pre-engraftment period in a bone marrow transplant recipi-
ent. Viridans streptococci are commonly isolated from the
blood cultures of bone marrow transplant recipients during
the pre-engraftment period.37 As members of the oral flora, it
is not unexpected that gemella species would also cross the
mucosal barrier and cause bacteraemia in those patients with
mucositis. The concomitant isolation of S mitis and E coli was
in line with the hypothesis that the oral flora was the source of
the bacteraemia in case 2 (in immunocompromised patients,
part of the normal oral flora is replaced by enterobacteriaceae
and non-fermentative Gram negative bacilli).
The emergence of penicillin and macrolide resistance in
gemella species is of great concern. In the past, all gemella
Figure 1 Phylogenetic tree showing the relation of the two gemella
isolates to other species. The tree was inferred from 16S rRNA
sequencing data by the neighbour joining method. The scale bar
indicates the estimated number of substitutions for each 100 bases
using the Jukes-Cantor correction. Names and accession numbers
are given as cited in the GenBank database.
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species isolated from clinical specimens were highly sensitive
to penicillin G and ampicillin.38 In 1993, a strain of glycopep-
tide resistant G haemolysans that showed reduced susceptibility
to penicillin (minimum inhibitory concentration (MIC) of
0.5 µg/ml) was recovered from the blood culture of a 20month
old boy.39 In 1996, another strain of G morbillorum that was
resistance to penicillin (MIC of > 4 µg/ml) was recovered
from the blood culture of an 11 year old girl with nasopharyn-
geal Burkitt’s lymphoma.40 In our present series, one of the two
gemella strains showed reduced susceptibility to penicillin
(MIC of 0.5 µg/ml). Furthermore, it was also resistant to
erythromycin, clarithromycin, and azithromycin. Because
amoxicillin or macrolides are used as prophylaxis for infective
endocarditis, the rising incidence of penicillin and macrolide
resistance may mean the failure of these agents in the
prophylaxis of infective endocarditis in a considerable
proportion of these patients undergoing dental or other inva-
sive procedures.
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Take home messages
• Gemella bacteraemia is rare and 16S rRNA gene sequenc-
ing should be the method of choice for identification of
gemella and gemella-like isolates
• The identification of “gemella-like” species by the commer-
cial kits was unsatisfactory, especially when the Vitek
system (GPI) was used
• Species of gemella are important causes of infective endo-
carditis and one of the two patients reported here had
gemella endocarditis
• The other patient was a bone marrow transplant recipient
who had gemella bacteraemia during the pre-engraftment
period and the oral flora was the source of the bacteraemia
in this case
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